Your browser doesn't support javascript.
loading
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa.
Bowen, Charles M; Deng, Nan; Reyes-Uribe, Laura; Parra, Edwin Roger; Rocha, Pedro; Solis, Luisa M; Wistuba, Ignacio I; Sepeda, Valerie O; Vornik, Lana; Perloff, Marjorie; Szabo, Eva; Umar, Asad; Sinha, Krishna M; Brown, Powel H; Vilar, Eduardo.
Afiliação
  • Bowen CM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Deng N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Rocha P; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Solis LM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Sepeda VO; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Vornik L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Perloff M; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
  • Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
  • Umar A; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
  • Sinha KM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Brown PH; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Immunol ; 14: 1162669, 2023.
Article em En | MEDLINE | ID: mdl-37207208
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Vacinas Anticâncer / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Vacinas Anticâncer / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça